We serve Chemical Name:Methyl 2-chloro-5,6-dimethoxypyrimidine-4-carboxylate CAS:923938-13-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Methyl 2-chloro-5,6-dimethoxypyrimidine-4-carboxylate
CAS.NO:923938-13-0
Synonyms:Methyl 2-chloro-5,6-dimethoxypyrimidine-4-carboxylate
Molecular Formula:C8H9ClN2O4
Molecular Weight:232.62100
HS Code:2933599090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:70.54000
Exact Mass:232.02500
LogP:0.93380
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Methyl 2-chloro-5,6-dimethoxypyrimidine-4-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 2-chloro-5,6-dimethoxypyrimidine-4-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 2-chloro-5,6-dimethoxypyrimidine-4-carboxylate Use and application,Methyl 2-chloro-5,6-dimethoxypyrimidine-4-carboxylate technical grade,usp/ep/jp grade.
Related News: The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances. Methyl 2-chloro-5,6-dimethoxypyrimidine-4-carboxylate manufacturer The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. Methyl 2-chloro-5,6-dimethoxypyrimidine-4-carboxylate supplier The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. Methyl 2-chloro-5,6-dimethoxypyrimidine-4-carboxylate vendor It also said it would bar South Koreans from visiting China as tourists. Methyl 2-chloro-5,6-dimethoxypyrimidine-4-carboxylate factory Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells.
